Subscribe To
ACRX / AcelRx: Battered And Bruised But Ready For Recovery In 2022
ACRX News
By Seeking Alpha
August 10, 2023
AcelRx Pharmaceuticals, Inc. (ACRX) Q2 2023 Earnings Call Transcript
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Raffi Asadorian – Chief more_horizontal
By Zacks Investment Research
August 10, 2023
AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue Estimates
AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares more_horizontal
By Zacks Investment Research
May 10, 2023
AcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1
AcelRx Pharmaceuticals (ACRX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares t more_horizontal
By Seeking Alpha
March 30, 2023
AcelRx Pharmaceuticals Inc. (ACRX) Q4 2022 Earnings Call Transcript
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX ) Q4 2022 Results Conference Call March 30, 2023 4:30 PM ET Company Participants Raffi Asadorian - Chief Fina more_horizontal
By Zacks Investment Research
March 30, 2023
AcelRx Pharmaceuticals (ACRX) Reports Q4 Loss, Lags Revenue Estimates
AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of -900% and 97.04%, respectively, for the quarter ended December 2022. Do the more_horizontal
By PRNewsWire
March 21, 2023
AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
HAYWARD, Calif. , March 21, 2023 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the devel more_horizontal
By Seeking Alpha
November 14, 2022
AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2022 Results - Earnings Call Transcript
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX ) Q3 2022 Results Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Raffi Asadorian more_horizontal
By Zacks Investment Research
November 14, 2022
AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates
AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 21.67% and 7.82%, respectively, for the quarter ended September 2022. Do the more_horizontal